Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Tornado chasers

Storm chasers brave danger and debris as they try to capture photos of tornadoes' destructive power.  Slideshow 

Photo

Running while blind

Blind or visually impaired students compete in blind track and field tournament.  Slideshow 

Sponsored Links

Skin cells transformed directly to nerve in study

Related Topics

Researchers at Stanford University in California have transformed the ordinary cells of mice directly into nerve cells called neurons using just three genes, in a move they hope can transform the field of regenerative medicine. These cells are stained red with a compound that identifies them as neurons. REUTERS/Thomas Vierbuchen/Marius Wernig, Institute for Stem Cell Biology and Regenerative Medicine at Stanford University

Researchers at Stanford University in California have transformed the ordinary cells of mice directly into nerve cells called neurons using just three genes, in a move they hope can transform the field of regenerative medicine. These cells are stained red with a compound that identifies them as neurons.

Credit: Reuters/Thomas Vierbuchen/Marius Wernig, Institute for Stem Cell Biology and Regenerative Medicine at Stanford University

WASHINGTON | Wed Jan 27, 2010 3:16pm EST

WASHINGTON (Reuters) - Researchers have transformed ordinary mouse skin cells directly into neurons, bypassing the need for stem cells or even stemlike cells and greatly speeding up the field of regenerative medicine.

The experiment could make it possible to someday take a sample of a patient's skin and turn the cells into a tailor-made transplant to treat brain diseases such as Parkinson's or Alzheimer's, or heal damaged spinal cords.

"This study is a huge leap forward," said Dr. Irving Weissman, director of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University in California, where the work was done and where it has been patented.

Although they worked with mice, past stem cell accomplishments have been replicated in humans within months.

The researchers also hope they can reprogram ordinary cells into other cell types to help replace damaged livers, treat diabetes and treat cancer.

Writing in the journal Nature, the researchers said they used just three genes to transform ordinary mouse skin cells directly into nerve cells called neurons. They are calling the new cells "induced neuronal cells".

"We actively and directly induced one cell type to become a completely different cell type," said Dr. Marius Wernig of Stanford, who led the study.

"These are fully functional neurons. They can do all the principal things that neurons in the brain do."

Wernig said he was surprised at his team's success. Scientists had thought they would have to make cells regress to a more primitive state before they could make them change direction.

"To be very honest, I wasn't sure if it would work. It was one of those high-risk, high reward projects," Wernig said in a telephone interview. "It worked out, actually relatively quickly."

The team is already trying the same thing with human cells but Wernig says it appears to be a little trickier.

NO MORE STEM CELLS?

Efforts to do this kind of thing have focused on human embryonic stem cells, which retain the ability to become any kind of cell in the body. But their use is controversial and restricted.

In recent years, scientists have also found a way to regress skin cells into embryonic-like cells called induced pluripotent stem cells.

This experiment skips all those intermediate steps and although it does not immediately mean there is no need to use embryonic stem cells, it suggests a way to bypass them.

One drawback to the new cells is that they do not proliferate well in the lab and do not live for as long as the more primitive stem cells. But Wernig said he believes it will be possible to transform skin cells into all types.

"You just need to find the right transcription cocktail and you can turn anything you want into anything you want," he said.

Transcription factors are genes that tell other genes what to do. Every cell in the body contains the entire DNA map, known as the genome, but only certain genes operate in certain cells.

The ultimate goal behind all stem cell research has been to find a way to instruct cells to do something different. Wernig said his team's experiment tells scientists which genes they need to activate to do this.

The new cells could be transplanted, or grown in the lab to study diseases.

But it may be possible to also activate these three genes in the body using a drug or some other method.

"That would have fantastic implications," said Wernig.

"In the brain, for example, when there is a stroke or some other kind of lesion, there is often an overproliferation of nerve cells called glial cells. If you could turn those into neurons it would be fantastic."

(Editing by David Storey)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (4)
feeed wrote:
This “Huge” Leap Forward is EXACTLY what Dr. Shinya Yamanaka did in 2006. This So Called “Huge” process if a clinical Phase 1 at the FDA started tomorrow is at LEAST a decade away from commercial applications. For the Doctor say it is “patented” is a mis-statement or a mis-quote. It has NOT. check the U.S. patent office as I did. Lastly the “PUMP” on this is NOT founded. The researchers saying “great leap forward” is NONsense. With out the FDA and NIH and other industry experts say so.

Right now millions of dieing/sick people need stem cells and the proven research that has gone on for 15yrs. For these researchers to act like they Found the Holy grail with OUT clinical trials is foolhardy and absolutly unprofessional.
Only TWO Companys have been authorized to conduct HUMAN Stem Cell commercialization Process Clinicals. Geron Corp in 1/23/09 which is under a clinical Hold until q-3 2010 and Advanced Cell Technology which submitted its IND for Stargardts Disease (SMD) for its RPE program. ACT’s no harm to embryo Stem Cell process should be the one to be spoken about on this and every other subject when it comes to “ETHICAL” stem Cell harvesting.

feeed

Jan 27, 2010 1:46pm EST  --  Report as abuse
blancokat wrote:
At last, science unfettered by politics to provide hope for those needing cures for life-limiting diseases. Waiting a decade (or two) for help is nothing compared to living a lifetime without hope.

Jan 27, 2010 2:46pm EST  --  Report as abuse
feeed wrote:
This article is ALL over the Internet. What absolute farse. Advanced Cell Technology ALREADY has the ETHICAL Debate Solved with its “Blastomere” Process. It is ALMOST identical to the IVF clinic process of testing ONE CEll from an Embryo to ensure it is HEALTHY. Advanced Cell Technology gets this ONE CELL from the Embryo with OUT Harming it. Why has this been ignored? Is it because it is a Public Company that is ALSO an Ethical Company that does not pander to the Far Left and Far Right? Where is ACT’s ARTICLES of “Ethical”Solving of the Embryo/StemCell Issue? ACT SOLVED THIS PROBLEM ALMOST 2YRS AGO. BUT STILL TO THIS DAY IT IS IGNORED. When ACT is the FIRST Company authorized by the FDA to start HUMAN commercialization Clinical Process from its “NO HARM/Blastomere” process of StemCell “maybe” just maybe the DEBATE will be over and WE can Heal people with this ACT process instead of fight over embryos”? Enough is enough.
BTW, That article Today HAD zero credibility in that it made it SOUND like it could Start healing tomorrow! Giving SICK and Dieing people Unfounded hope is shameful and out right wrong. Glad they found something unusual, I want it to go thru Animal Clinical’s FIRST before it is deemed the Holy Grail! In the mean time, lets use ACT’s Blastomere process.

feeed

Jan 27, 2010 9:08pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.